Asthma Clinical Trial
Official title:
Evaluation of the Effectiveness of a Technology-based Program Delivered by Peer-led and Adult Educators to Adolescents Diagnosed With Asthma
The research was planned in a randomized controlled trial to evaluate the effect of technology-based education provided by peers and adults to children diagnosed with asthma in the 12-18 age group. The study will be conducted in two phases. The initial phase will assess the efficacy of the training provided to peer mentors. The subsequent phase will examine the impact of peer-led and adult-delivered technology-based education on quality of life, asthma control, asthma knowledge, and self-efficacy in adolescents diagnosed with asthma. The required institutional permission and ethics committee approval was received. The study group of the study will consist of 45 adolescents (intervention group 1 [n=15], intervention group 2 [n=15], and control group [n=15]). Data will be collected by using the descriptive features form, the Adolescent Asthma Self-Efficiacy Questionaire, the Asthma Quality of Life Scale for Children, the Asthma Control Test, the Asthma Knowledge Test.The data will be analyzed using the SPSS 27 program.
Asthma is the most common chronic disease in children. Although asthma often occurs in childhood, it can occur at any age. The incidence and prevalence of asthma is higher in children. On average, 5-10% of the world's population has an individual diagnosed with asthma, and one-third of these individuals are under the age of 18. In the United States of America (USA), approximately 6 million children between the ages of 0-17 are diagnosed with asthma. It has been reported that adolescents are at high risk for poor asthma outcomes, and death rates from asthma are twice as high in the 11-17 age group than in the 0-10 age group. Peer relationships and peer support are of particular importance for children with chronic illnesses. Adolescents diagnosed with asthma value support from their peers. Adolescents tend to seek guidance from people with similar characteristics, and the opinions of individuals with similar characteristics are more valuable than those of individuals who do not have similar characteristics. Being with an adolescent diagnosed with asthma can improve the adolescent's sense of support and sense of normalcy. It is crucial to create an environment where adolescents diagnosed with asthma can interact with other adolescents diagnosed with asthma, thereby facilitating the formation of a support network.The research was planned in a randomized controlled trial to evaluate the effect of technology-based education provided by peers and adults to children diagnosed with asthma in the 12-18 age group. The study group of the study will consist of 45 adolescents (intervention group 1 [n=15], intervention group 2 [n=15], and control group [n=15]). The technology-based program will be applied to adolescents for 4-6 weeks through modules on the website. At the end of the study, it will apply website modules to the adolescents in the control group. The research is based on the Bandura's Self-Efficacy Theory. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|